Cyclin D1 expression in B-cell non Hodgkin lymphoma

References

• Devesa SS, Fears T. Non-Hodgkin’s lymphoma lime trends: United States and international data. Cancer Res 1992; 52( Suppl):5432–5440.
   PubMed Web of Science ®Google Scholar
• Peters G, Bates S, Pary D. The D-cyclins, their kinases, and their inhibitors in apoptosis and cell cycle control in cancer. In: Thomas N, editor. Vol. 2. Oxford: Oxford Publisher; 1996. p 37–45.
   Google Scholar
• Sherr CJ. Cancer cell cycles. Science (Washington DC) 1996;274:1672–1677.
   PubMed Web of Science ®Google Scholar
• Michalides RJAM. Cell cycle regulators: Mechanisms and their role in aetiology, prognosis, and treatment of cancer. J Clin Pathol 1999;52:555–568.
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y, Yunis Y, Onorato-Showe L, Erikson J, Nowell PC, Croce CM. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science (Washington DC) 1984;224: 1403–1406.
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y, Jaffe ES, Cossman J, Gorham J, Nowell PC, Croce CM. Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature (London) 1985;315:343–345.
   PubMed Web of Science ®Google Scholar
• Arnold A, Kim HG, Gaz RD, Eddy RL, Fukushima Y, Byers MG, Shows TB, Kronenberg HM. Molecular cloning and chromosomal mapping of DNA rearranged with the para-thyroid hormone gene in a parathyroid adenoma. J Clin Invest 1989;83:2034–2040.
   PubMed Web of Science ®Google Scholar
• Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A. A novel cyclin encoded by a bell-linked candidate oncogene. Nature (London) 1991; 350:512–515.
   PubMed Web of Science ®Google Scholar
• Campo E, Raffeld M, Jaffe ES. Mantle-cell lymphoma. Semin Hematol 1999;36:115–127.
   PubMed Web of Science ®Google Scholar
• Chesi M, Bergsagel PL, Brents LA, Smith CM, Gerhard DS, Kuehl WM. Dysregulation of cyclin DI by translocation into an IgH y switch region in two multiple myeloma cell lines. Blood 1996;88:674–681.
   PubMed Web of Science ®Google Scholar
• Bosch F, Jares P, Campo E, Lopez-Guillermo A, Pins M, Villamor N, Tassies D, Jaffe ES, Montserrat E, Rozman C, Cardesa A. PRAD-1/cyclin D1 gene over expression in chronic lymphoproliferative disorders: A highly specific marker of mantle cell lymphoma. Blood 1994;84: 2726–2732.
   PubMed Web of Science ®Google Scholar
• Brito-Babapulle V, Pittman S, Melo JV, Pomfret M, Catovsky D. Cytogenetic studies on prolymphocytic leukemia. I. B-cell prolymphocytic leukemia. Hematol Pathol 1987;1:27–33.
   PubMedGoogle Scholar
• Ronchetti D, Finelli P, Richelda R, Baldini L, Rocchi M, Viggiano L, Cuneo A, Bogni S, Fabris S, Lombardi L, Maiolo A, Ned A. Molecular analysis of 11q13 breakpoints in multiple myeloma. Blood 1999;93:1330–1337.
   PubMed Web of Science ®Google Scholar
• Bosch F, Campo E, Jares P, Pittaluga S, Munoz J, Nayach I, Pins MA, Dewolf-Peeters C, Jaffe ES, Rozman C, Cardesa A. Increased expression of the PRAD-1/CCND1 gene in hairy cell leukemia. Br J Haematol 1995;91: 1025–1030.
   PubMed Web of Science ®Google Scholar
• de Boer CJ, Kluin-Nelemans JC, Dreef E, Kester MG, Kluin PM, Schuuring E, van Krieken JH. Involvement of the CCND1 gene in hairy cell leukemia. Ann Oncol 1996; 7:251–256.
   PubMed Web of Science ®Google Scholar
• Delmer A, Ajchenbaum-Cymbalista F, Tang R, Ramond S, Faussat AM, Marie JP, Zittoun R. Over-expression of cyclin D1 in chronic B cell malignancies with abnormality of chromo-some 11q13. Br J Hematol 1995;89:798–804.
   PubMed Web of Science ®Google Scholar
• Stilgebauer S, Winkler D, Ott G. Molecular characterization of 1q deletions points to a pathogenetic role he ATM gene in mantle cell lymphoma. Blood 1995;94: 3262–3264.
   Google Scholar
• Aref S, Fouda M, El-Dosoky E, Menessy A, Mabed M, Saleeb M, Zalata K. C-Myc oncogene and cdc25A cell activating phosphate expression in NHL. Hematology 2003;8: 183–190.
   PubMedGoogle Scholar
• Dacie JV, Lewis SM. Tests for acute phase response. In: Dacie V, Lewis SM, editors. Practical hematology. Vol. 29. London: Churchill Livingstone; 1999. p 561.
   Google Scholar
• Miyatake S, Nakano H, Park SY, Yamazaki T, Takase K, Matsushime H, Kato A, Saito T. Induction of G1 arrest by down-regulation of cyclin D3 in T-cell hybridomas. J Exp Med 1995;182:401–408.
   PubMed Web of Science ®Google Scholar
• Uchimaru K, Taniguchi T, Yoshikawa M, Asano S, Arnold A. Detection of Cyclin D1 (bcl-1, PRADI) over-expression by a simple competitive reverse trans-cription polymerase chain reaction assay in t(ll;14) (q!3;q32)-bearing B-cell malignancies and/or mantle cell lymphoma. Blood 1997;89: 965–974.
   PubMed Web of Science ®Google Scholar
• Yatabe Y, Suzuki R, Tobinai K, Matsuno Y, Ichinohasama R, Okamoto M, Yamaguchi M, Tamaru J, Uike N, Hashimoto Y, Morishitna Y, Suchi T, Seto M, Nakamura S. Significance of cyclin DI over expression for the diagnosis of mantle cell lymphoma: A clinicopathologic comparison of cyclin D1-positive MCL and cyclin DI-negative MCL-like B-cell lymphoma. Blood 2000;95:2253–2261.
   PubMed Web of Science ®Google Scholar
• Jain P, Giustolisi GM, Atkinson S, Elenaei MO, Morilla R, Owusu-Ankomah K, Rafiq-Mohammed F, Matutes E, Wotherspoon A, Catovsky D. Detection of cyclin Dl in B-cell lymphoproliferative disorders by flow-cytometry. J Clin Pathol 2002;55:940–945.
   PubMed Web of Science ®Google Scholar
• De Boer CJ, Kluin- Nelemans JC, Dreef E, Kester MG, Kluin PM, Schuuring E, van Krieken JH. Involvement of the CCND1 gene in hairy cell leukemia. Ann Oncol 1996; 7:251–256.
   PubMed Web of Science ®Google Scholar
• Alkan S, Schnitzer B, Thompson JL, Moscinski LC, Ross CW. Cyclin Dl protein expression in mantle cell lymphoma. Ann Oncol 1995;6:567–570.
   PubMed Web of Science ®Google Scholar
• Sola B, Roue G, Duquesne F, Avet-Loiseau H, Macro M, Salaun V, Troussard X. Expression of cyclins D-types in B-chronic lymphoproliferative disorders. Leukemia 2000; 1318–1319.
   PubMed Web of Science ®Google Scholar
• Ott MM, Bartkova J, Bartek J, Dun A, Fischer L, Ott G, Muller-Hermelink HK, Kreipe H. Cyclin Dl expression in mantle cell lymphoma is accompanied by down-regulation of cyclin D3 and is not related to the proliferate activity. Blood 1997;90: 3154–3159.
   PubMed Web of Science ®Google Scholar
• Zukerberg LR, Benedict WF, Arnold A, Dyson N, Harlow E, Harris NL. Expression of the Retinoblastoma protein in low-grade B-cell lymphoma: Relationship to cyclin Dl. Blood 1996;881:268.
   Google Scholar
• Aguilera NS, Bijwaard RE, Duncan B, Krafft AE, Chu WS, Abbondanzo SL, Lichy JH, Taubenberger JK. Differential expression of cyclin Dl in mantle cell lymphoma and other non-Hodgkin’s lymphomas. Am J Pathol 1998;153: 1969–1976.
   PubMed Web of Science ®Google Scholar
• Levy V, Ugo V, Delmer A, Tang R, Ramond S, Perrot JY, Vrhovac R, Marie JP, Zittoun R, Ajchenbaum-Cymbalista F. Cyclin Dl over expression allows identification of an aggressive subset of leukemic lymphoproliferative disorder. Leukemia 1999;108:114.
   Google Scholar
• Au WY, Horsman DE, Gascoyne RD, Viswanatha DS, Klas RJ. The spectrum of lymphoma with 8q24 aberration: A clinical, pathological and cytogenetic study of 87 consecutive cases. Leuk Lymphoma 2004;45: 519–528.
   PubMed Web of Science ®Google Scholar